WangLRBarberCEJohnsonASBarnabeC. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum2014; 44: 325–330.
2.
JamesJALupus and infections. In: WallaceDJHahnBH (eds). Dubois’ lupus erythematosus and related syndromes20199th ed. Elsevier Inc., pp. 543–555.
3.
Torres-RuizJMejía-DomínguezNRZentella-DehesaA, et al.The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): a clinical-immunological tool to predict infections in lupus patients. Front Immunol2019; 9: 3144–3144.
4.
Ruiz-IrastorzaGOlivaresNRuiz-ArruzaIMartinez-BerriotxoaAEgurbideM-VAguirreC. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther2009; 11: R109–R109.
5.
BoschXGuilabertAPallarésL, et al.Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus2006; 15: 584–589.
6.
OzakiTYamashitaHKanekoS, et al.Cytomegalovirus disease of the upper gastrointestinal tract in patients with rheumatic diseases: a case series and literature review. Clin Rheumatol2013; 32: 1683–1690.
7.
GardinerBJHaasEMBaileyRCChowJKSnydmanDR. Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case-control study. Rheumatol Int2019; 39: 1229–1240.
8.
BermanNBelmontHM. Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem. Lupus2017; 26: 431–434.
9.
ChenDXieJChenH, et al.Infection in Southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol2016; 43: 1650–1656.
10.
Ruderman EM, Flaherty JP. Fungal infections of bones and joints. In: Kelley and Firestein’s textbook of rheumatology. 10th ed. Elsevier Inc., 2017, pp.1918–1928.